| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.96B | 8.72B | 49.73B | 46.04B | 46.74B | 43.34B |
| Gross Profit | 21.96B | 12.37B | 49.46B | 46.04B | 46.74B | 43.34B |
| EBITDA | 0.00 | 4.27B | -23.00M | 1.64B | -573.00M | 115.00M |
| Net Income | 2.38B | 3.24B | 3.21B | 472.00M | 1.44B | -878.00M |
Balance Sheet | ||||||
| Total Assets | 135.34B | 127.23B | 179.58B | 170.68B | 181.57B | 182.62B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 88.64B | 88.38B | 85.61B | 4.15B | 4.70B |
| Total Debt | 8.47B | 7.26B | 9.82B | 11.04B | 11.19B | 11.74B |
| Total Liabilities | 111.27B | 103.99B | 163.21B | 157.87B | 10.32B | 11.58B |
| Stockholders Equity | 23.93B | 23.11B | 16.15B | 12.70B | 23.57B | 27.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.13B | 4.09B | 2.93B | 4.10B | 5.39B |
| Operating Cash Flow | 0.00 | 3.13B | 4.09B | 2.93B | 4.10B | 5.39B |
| Investing Cash Flow | 0.00 | -407.00M | -362.00M | -2.34B | -2.14B | -7.72B |
| Financing Cash Flow | 0.00 | -2.97B | -3.22B | -1.24B | -2.10B | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | CHF85.12B | 16.92 | 23.97% | 4.66% | -7.33% | 17.93% | |
73 Outperform | CHF35.82B | 12.15 | 17.22% | 4.52% | -4.94% | -5.71% | |
70 Outperform | CHF2.06B | 13.75 | 6.06% | 3.38% | -1.58% | 4.07% | |
68 Neutral | CHF8.94B | 20.39 | ― | 4.09% | -9.11% | 73.67% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
68 Neutral | CHF25.87B | 22.02 | 17.11% | 3.83% | -1.65% | 10.05% | |
59 Neutral | CHF10.64B | 19.44 | ― | 3.40% | -1.57% | 95.56% |
Swiss Re has announced its strategic goals for 2026, aiming for a group profit of USD 4.5 billion, supported by a renewed strategy that emphasizes disciplined execution and leveraging AI to enhance productivity and decision-making. The company plans to introduce a sustainable annual share buyback program starting in 2026, contingent on achieving a group profit of more than USD 4.4 billion in 2025. Swiss Re has largely completed its review of underperforming portfolios in Life & Health Reinsurance, with an estimated impact on IFRS pre-tax profit of USD 250 million in the fourth quarter. The group maintains its targets for return on equity and dividend growth, while also focusing on reducing operating expenses by USD 300 million by 2027.
Swiss Re has announced the appointment of Nicole Pieterse as the new Chief People Officer, effective January 1, 2026, succeeding Cathy Desquesses. Pieterse, who has been with Swiss Re since 2015 and currently serves as Head of Human Resources at Property & Casualty Reinsurance, is recognized for her extensive leadership experience in HR within the financial services industry. This leadership change is seen as a strategic move to continue advancing Swiss Re’s personnel strategy, with the company’s executives expressing confidence in Pieterse’s ability to contribute to its ongoing transformation and success.
Swiss Re Institute’s latest report highlights significant structural changes in the global economy driven by increased government spending, industrial policy, aging populations, and artificial intelligence. These factors are reshaping the risk landscape and impacting global GDP growth, which is expected to stabilize at around 2.5% in the coming years. The insurance industry is poised to benefit from these changes, with global insurance premiums projected to grow by 2.3% annually. However, challenges such as high inflation, fiscal dominance, and potential inefficiencies in industrial policy pose risks. The aging population is shifting demand towards longevity and health coverage, while AI is transforming insurance workflows. Despite these challenges, the insurance market remains robust, with strong profitability and high solvency ratios.
Swiss Re reported a significant profit increase to USD 4.0 billion for the first nine months of 2025, driven by strong underwriting results and solid investment returns. The Property & Casualty Reinsurance division notably improved its combined ratio, benefiting from lower natural catastrophe losses, while Corporate Solutions and Life & Health Reinsurance also contributed positively, despite some challenges. The company’s robust financial performance underscores its strategic focus on underwriting quality and resilience, positioning it well to achieve its full-year profit target.
Swiss Re’s latest report highlights the significant impact of the global energy transition on risk markets, with investments in energy transition, climate mitigation, and adaptation expected to exceed USD 80 trillion by 2040. The report projects that renewable energy capacity will nearly double by 2030, generating substantial insurance premiums, particularly in Asia-Pacific and Europe. As renewable portfolios mature, insurance needs are shifting towards long-term operational resilience, with new claims trends necessitating closer integration between underwriting and real-world data.
Swiss Re’s latest sigma report highlights the transformative impact of the ‘Silver Economy’ on the life insurance industry, driven by an aging population, declining birth rates, and wealth concentration among seniors. By 2050, a significant portion of the population in industrialized countries will be over 65, necessitating a shift in life insurers’ focus from income replacement to wealth planning and personal care financing. This demographic shift presents opportunities for insurers to innovate in product design and delivery, addressing the needs of retirees who face the risk of outliving their savings. The report emphasizes the importance of developing new financial products, such as longevity risk distribution pools and cancer-specific insurance, to meet the evolving demands of an aging population, while also highlighting the growing pressure on long-term care services.
Swiss Re’s recent study highlights the potential impact of GLP-1 medications on reducing mortality rates in the USA and UK by 2045, assuming widespread use and lifestyle changes. The study emphasizes the importance of lifestyle modifications alongside medication use to achieve significant mortality reductions, with implications for insurers in risk assessment and benefit claims development.
Swiss Re emphasizes the importance of a holistic approach to maintaining resilience amid complex risks, highlighting the role of AI in improving risk assessment and underwriting quality. The company underscores the urgency of preventive measures against natural disasters and stresses the need for collaboration between public and private sectors to mitigate risks. Geopolitical uncertainties and fragmentation pose challenges to the re/insurance market, affecting risk assessment and causing volatility. Swiss Re views re/insurance as a stabilizing force during global upheavals, supporting economic recovery and resilience.